Inhibiting TBK1 by amlexanox increased the insulin-stimulated phosphorylation rate of AKT, increased insulin sensitivity and decreased glucose tolerance in HFD-fed mice and ob/ob mice 81 as well as in patients with T2DM 100. The gene discussed is INS; the disease is type 2 diabetes mellitus.